Position in GSK
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$490,651
-$25,927 QoQ
Shares Held
9,360
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#487
of 1,033 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHELSEA COUNSEL CO holds $9,679,558 across 10 Drug Manufacturers - General names. GSK ranks #3 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
17,904 | $4,547,078 | |
| 2 | AMGN |
Amgen Inc
|
8,954 | $3,242,422 | |
| 3 | GSK |
GSK plc
This page
|
9,360 | $490,651 | |
| 4 | PFE |
Pfizer Inc
|
20,000 | $481,600 | |
| 5 | LLY |
ELI LILLY & Co
|
351 | $420,999 | |
| 6 | MRK |
Merck & Co., Inc.
|
2,840 | $364,940 | |
| 7 | SNY |
Sanofi
|
1,845 | $78,707 | |
| 8 | ABBV |
AbbVie Inc.
|
114 | $28,686 |
All Filings in GSK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $490,651 | 9,360 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $516,578 | 9,360 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $459,014 | 9,360 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $403,977 | 9,360 | Shares | Sole | 2025-11-25 | |
| 2025-06-30 | $359,424 | 9,360 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $362,606 | 9,360 | Shares | Sole | 2025-05-22 | |
| 2024-12-31 | $992,955 | 29,360 | Shares | Sole | 2025-02-27 | |
| 2024-09-30 | $1,200,236 | 29,360 | Shares | Sole | 2024-11-21 | |
| 2024-06-30 | $1,130,360 | 29,360 | Shares | Sole | 2024-11-21 | |
| 2024-03-31 | $1,258,663 | 29,360 | Shares | Sole | 2024-06-17 | |
| 2023-12-31 | $1,088,081 | 29,360 | Shares | Sole | 2024-02-21 | |
| 2023-09-30 | $1,064,300 | 29,360 | Shares | Sole | 2023-11-22 | |
| 2023-06-30 | $1,046,390 | 29,360 | Shares | Sole | 2023-11-22 | |
| 2023-03-31 | $1,044,628 | 29,360 | Shares | Sole | 2023-05-19 | |
| 2022-12-31 | $1,031,710 | 29,360 | Shares | Sole | 2023-02-23 | |
| 2022-09-30 | $864,064 | 29,360 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $1,566,878 | 36,700 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $1,567,957 | 36,700 | Shares | Sole | 2022-05-24 | |
| 2021-12-31 | $1,587,395 | 36,700 | Shares | Sole | 2022-05-23 | |
| 2021-09-30 | $1,375,382 | 36,700 | Shares | Sole | 2022-02-10 | |
| 2021-06-30 | $1,433,335 | 36,700 | Shares | Sole | 2022-02-10 | |
| 2021-03-31 | $1,284,674 | 36,700 | Shares | Sole | 2022-02-10 | |
| 2020-12-31 | $1,324,629 | 36,700 | Shares | Sole | 2022-03-08 | |
| 2020-09-30 | $1,354,865 | 36,700 | Shares | Sole | 2022-05-06 | |
| 2020-06-30 | $1,468,250 | 36,700 | Shares | Sole | 2022-05-06 | |
| 2020-03-31 | $1,363,864 | 36,700 | Shares | Sole | 2020-06-12 | |
| No filing history on record for this holder in this stock. | ||||||